Skip to content
Trial Eligibility
Menu

Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout

NCT06887452

This study is recruiting at 5 US sites in 5 states, according to its ClinicalTrials.gov record last updated .

Summary

This study will compare two different approaches to manage medications that lower uric acid levels. This study will be conducted at five VA medical centers across the United States and will take 4-5 years to complete. Individual participation will last up to two years.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Gout
  • Gouty Arthritis

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
VA Office of Research and Development
Last updated on ClinicalTrials.gov
October 21, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Nebraska · 1

  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE · Omaha, NE

Oregon · 1

  • VA Portland Health Care System, Portland, OR · Portland, OR

Pennsylvania · 1

  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA · Philadelphia, PA

Utah · 1

  • VA Salt Lake City Health Care System, Salt Lake City, UT · Salt Lake City, UT

Washington · 1

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA · Seattle, WA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.